Prevention and treatment of cancers by immune modulating nutrients - PubMed (original) (raw)
Review
Prevention and treatment of cancers by immune modulating nutrients
Naveena B Janakiram et al. Mol Nutr Food Res. 2016 Jun.
Abstract
Epidemiological and laboratory data support the protective effects of bioactive nutrients in our diets for various diseases. Along with various factors, such as genetic history, alcohol, smoking, exercise, and dietary choices play a vital role in affecting an individual's immune responses toward a transforming cell, by either preventing or accelerating a neoplastic transformation. Ample evidence suggests that dietary nutrients control the inflammatory and protumorigenic responses in immune cells. Immunoprevention is usually associated with the modulation of immune responses that help in resolving the inflammation, thus improving clinical outcome. Various metabolic pathway-related nutrients, including glutamine, arginine, vitamins, minerals, and long-chain fatty acids, are important components of immunonutrient mixes. Epidemiological studies related to these substances have reported different results, with no or minimal effects. However, several studies suggest that these nutrients may have immune-modulating effects that may lower cancer risk. Preclinical studies submit that most of these components may provide beneficial effects. The present review discusses the available data, the immune-modulating functions of these nutrients, and how these substances could be used to study immune modulation in a neoplastic environment. Further research will help to determine whether the mechanistic signaling pathways in immune cells altered by nutrients can be exploited for cancer prevention and treatment.
Keywords: Bioactive agents; Cancer; Immune modulation; Macronutrients; Phytochemicals.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figures
Fig 1A:
Arginine and glutamine levels are to be balanced to achieve its tumor inhibiting functions. Both low levels and high levels of arginine is having negative effects on immune responses and tumor tissues. Low levels of arginine will lead to reduced infiltration of lymphocytes in tumor microenvironment. However, increased levels of arginine will eventually lead to sustained continuous production of NO and high levels of polyamines which help in tumor cell proliferation and development. Hence, a balanced concentrations of arginine is necessary for achieving best tumor inhibiting functions of arginine. B. A similar functions of glutamine are being discussed in this review. Lower glutamine levels results in reducing cytotoxic functions of NK cells leading to immune evasion of tumor cells. Increased levels of glutamine were reported in patients, resulting in increased T cells, and activation of DC in promoting TH17 immune cell responses, also resulting in tumor cell proliferation and tumor growth. Balancing the concentrations of glutamine is very important to achieve its beneficial effects on tumor inhibition.
Fig 2.
Tumor inhibitory functions of selenium: Selenium posses anti-inflammatory properties, along with other potent tumor inhibiting functions such as, inactivation of tumor cell promoting factors, blocking cell cycle regulation their by inhibit tumor invasion and metastases. Selenium is able to inhibit tumor-promoting functions by modulating various immune cell responses as listed above.
Fig 3A:
Anti-inflammatory and immune modulating effects of Phtochemicals. Curcumin enhances cytotoxicity of NK cells, and increase T effector, T memory cells and reduce T regulatory cells helping in inhibiting tumor growth. B. Flavanoids posses anti-inflammatory functions and also inhibit human pancreatic cancer stem cells. C. Stilbenes along with anti-inflammatory, anti-oxidant functions, it can polarize M1 and M2 macrophages helping in inhibition of tumors. D. Isothiocyanates increase proliferation of WBC cells. It can interact with Macrophage Inhibitory Factor (MIF) enhancing immune responses towards inhibition of tumor formation. Further, it was demonstrated to posses’ angiogenesis inhibitor properties.
Fig 4.
Polyunsaturated omega 3 fatty acids in inhibiting tumors. EPA and DHA interactions with lipid rafts in altering the immune cell responses and generate less potent 3 series and 5 series eicosanoid metabolites which will not promote tumor development
Similar articles
- Novel insights of dietary polyphenols and obesity.
Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL. Wang S, et al. J Nutr Biochem. 2014 Jan;25(1):1-18. doi: 10.1016/j.jnutbio.2013.09.001. J Nutr Biochem. 2014. PMID: 24314860 Free PMC article. Review. - Anticancer Efficacy of Polyphenols and Their Combinations.
Niedzwiecki A, Roomi MW, Kalinovsky T, Rath M. Niedzwiecki A, et al. Nutrients. 2016 Sep 9;8(9):552. doi: 10.3390/nu8090552. Nutrients. 2016. PMID: 27618095 Free PMC article. Review. - Nutritional modulation of immune function.
Grimble RF. Grimble RF. Proc Nutr Soc. 2001 Aug;60(3):389-97. doi: 10.1079/pns2001102. Proc Nutr Soc. 2001. PMID: 11681814 Review. - Cancer prevention by dietary bioactive components that target the immune response.
Ferguson LR, Philpott M. Ferguson LR, et al. Curr Cancer Drug Targets. 2007 Aug;7(5):459-64. doi: 10.2174/156800907781386605. Curr Cancer Drug Targets. 2007. PMID: 17691905 Review. - Dietary glycation compounds - implications for human health.
Hellwig M, Diel P, Eisenbrand G, Grune T, Guth S, Henle T, Humpf HU, Joost HG, Marko D, Raupbach J, Roth A, Vieths S, Mally A. Hellwig M, et al. Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16. Crit Rev Toxicol. 2024. PMID: 39150724
Cited by
- HLBT-100: a highly potent anti-cancer flavanone from Tillandsia recurvata (L.) L.
Lowe HIC, Toyang NJ, Watson CT, Ayeah KN, Bryant J. Lowe HIC, et al. Cancer Cell Int. 2017 Mar 7;17:38. doi: 10.1186/s12935-017-0404-z. eCollection 2017. Cancer Cell Int. 2017. PMID: 28286420 Free PMC article. - The immunomodulatory potential of natural compounds in tumor-bearing mice and humans.
Pan P, Huang YW, Oshima K, Yearsley M, Zhang J, Arnold M, Yu J, Wang LS. Pan P, et al. Crit Rev Food Sci Nutr. 2019;59(6):992-1007. doi: 10.1080/10408398.2018.1537237. Epub 2019 Feb 22. Crit Rev Food Sci Nutr. 2019. PMID: 30795687 Free PMC article. Review. - Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies.
Zhang S, Jia Z, Yan Z, Yang J. Zhang S, et al. Oncotarget. 2017 Apr 25;8(17):27892-27903. doi: 10.18632/oncotarget.15841. Oncotarget. 2017. PMID: 28427188 Free PMC article. - Recent Overview of Resveratrol's Beneficial Effects and Its Nano-Delivery Systems.
Bohara RA, Tabassum N, Singh MP, Gigli G, Ragusa A, Leporatti S. Bohara RA, et al. Molecules. 2022 Aug 12;27(16):5154. doi: 10.3390/molecules27165154. Molecules. 2022. PMID: 36014390 Free PMC article. Review. - Pretreatment Dietary Patterns, Serum Carotenoids and Tocopherols Influence Tumor Immune Response in Head and Neck Squamous Cell Carcinoma.
Argirion I, Arthur AE, Zarins KR, Bellile E, Crowder SL, Amlani L, Taylor JM, Wolf GT, McHugh J, Nguyen A, Mondul AM, Rozek LS; University of Michigan Head and Neck SPORE Program. Argirion I, et al. Nutr Cancer. 2021;73(11-12):2614-2626. doi: 10.1080/01635581.2020.1842895. Epub 2020 Dec 11. Nutr Cancer. 2021. PMID: 33307825 Free PMC article.
References
- Percival SS, Nutrition and Immunity: Balancing Diet and Immune Function. Nutrition Today 2011, 46, 12–17.
- Liu RH, Dietary bioactive compounds and their health implications. Journal of food science 2013, 78, A18–A25. - PubMed
- Manhart N, Stehle P, Nutritive amino acids--effective modulators of the immune response. Forum of nutrition 2002, 56, 151–154. - PubMed
- McMurray D, Cell-mediated immunity in nutritional deficiency. Progress in food & nutrition science 1983, 8, 193–228. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA094962/CA/NCI NIH HHS/United States
- R01 CA213987/CA/NCI NIH HHS/United States
- I01 BX003198/BX/BLRD VA/United States
- R01 CA109247/CA/NCI NIH HHS/United States
- N01 CN053300/CN/NCI NIH HHS/United States
- HHSN261201200013I/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources